Back on the molecule-thin surface of the Bubble, it was hard to find an analyst who didn't love tech-king Lucent
Wall Street wisdom:
- General consensus. Thirty-six analysts follow Lucent, but few of them are scattering roses at its feet today. Barely one in 10 rates the company a "buy"; 17 wafflers counsel "holding" the stock; and -- now that the company's playing in penny stock land -- 14 have bit the bullet and muttered the dreaded "sell."
- Revenues. Here's why. Analysts believe Lucent grew revenues by just under 2% this quarter, versus a year ago.
- Earnings. And they don't think any of the growth dropped to the bottom line, either. The consensus is for flat earnings of $0.04 per share.
Margin watch:
Reviewing the company's recent performance in transforming top-line sales into bottom-line profits, we see a mixed bag at Lucent:
Margins% |
6/04 |
9/04 |
12/04 |
3/05 |
6/05 |
9/05 |
---|---|---|---|---|---|---|
Gross |
42.0 |
41.8 |
42.1 |
41.9 |
42.4 |
43.7 |
Op. |
14.3 |
13.8 |
13.5 |
12.8 |
13.4 |
14.5 |
Net |
10.3 |
22.1 |
20.2 |
22.0 |
21.5 |
12.6 |
All data courtesy of Capital IQ, a division of Standard & Poor's. Data reflects trailing 12 months performance for the quarters ending in the named months.
Gross margins are inching up sequentially and showing noticeable improvement against their year-ago levels. Net and operating margins, on the other hand, are still wobbling from quarter to quarter.
Key ratios:
Now that the professional analysts have come around to seeing Lucent as the dog of a stock that it was half a decade ago, I'd love nothing more than to call them all wrong again and hang a "buy" tag around Lucent. But with only 6% projected long-term growth ahead of it, a P/E of 10 and a price-to-free-cash-flow ratio more than twice as large, I can't bring myself to use the "b" word here.
Competitors:
Facing competition in competitors ranging from high (Cisco
Fool contributor Rich Smith does not own shares of any company named above.